Genevieve Laforet

Company: Aspa Therapeutics

Job title: Vice President, Clinical Development

Seminars:

Panel Discussion: Discovering the Risk: Benefit Ratio of AAV Gene Therapies & Life Limiting Indications 11:30 am

• Understanding the difference in adverse event tolerance between the different target populations • Highlighting the balance between the risk associated with AAV gene therapy and the severity and life threatening capacity of the patient's disease • Curating individual risk: benefit ratios for individual patients to understand the need for the AAV gene therapy treatmentRead more

day: Day One

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.